New project of the Catalan Institute of Oncology to Promote tobacco dependence treatment in LatinAmerica
The Catalan Institute of Oncology (ICO) is one of 19 organizations worldwide selected to receive a financial award from Global Bridges Healthcare Alliance for Tobacco Dependence Treatment to expand work in the field of tobacco dependence treatment. The “Pfizer Independent Grants for Learning and Change” program, hosted by Mayo Clinic and Pfizer, is part of $2.3 million in awards to support healthcare professional training and advocacy around the world.
The project “Development and Dissemination of a Tobacco Cessation Training Program for Healthcare Professionals in Spanish-speaking Countries” lead by Dr. Cristina Martínez from the Tobacco Control Unit will be developed in collaboration with the training program e-oncologia. Its aim is to offer a tobacco cessation training program and addressed to health care professionals of three Spanish-speaking low and middle income countries (Bolivia, Guatemala, and Paraguay) and to assessed its impact. This training will capacitate health organizations to offer tobacco cessation aid to smoking patients, and then decrease tobacco-related diseases. The project has been awarded with $99.640 for the period 11/2014 to 11/2016.
WHO estimates that tobacco use will kill one billion people this century—with low- and middle- income nations affected disproportionately—unless immediate, decisive action is taken. This funding initiative will expand tobacco treatment programs among middle- and low-income countries.